Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor. 1990

V J Merluzzi, and K D Hargrave, and M Labadia, and K Grozinger, and M Skoog, and J C Wu, and C K Shih, and K Eckner, and S Hattox, and J Adams
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877.

A series of dipyridodiazepinones have been shown to be potent inhibitors of human immunodeficiency virus-1 (HIV-1) reverse transcriptase (RT). One compound, BI-RG-587, had a Ki of 200 nanomolar for inhibition of HIV-1 RT that was noncompetitive with respect to deoxyguanosine triphosphate. BI-RG-587 was specific for HIV-1 RT, having no effect on feline and simian RT or any mammalian DNA polymerases. BI-RG-587 inhibited HIV-1 replication in vitro as demonstrated by in situ hybridization, inhibition of protein p24 production, and the lack of syncytia formation in cultured human T cell lines and freshly isolated human peripheral blood lymphocytes. Cytotoxicity studies of BI-RG-587 on human cells showed a high therapeutic index (greater than 8000) in culture.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse

Related Publications

V J Merluzzi, and K D Hargrave, and M Labadia, and K Grozinger, and M Skoog, and J C Wu, and C K Shih, and K Eckner, and S Hattox, and J Adams
October 2004, Current HIV research,
V J Merluzzi, and K D Hargrave, and M Labadia, and K Grozinger, and M Skoog, and J C Wu, and C K Shih, and K Eckner, and S Hattox, and J Adams
February 1995, Science (New York, N.Y.),
V J Merluzzi, and K D Hargrave, and M Labadia, and K Grozinger, and M Skoog, and J C Wu, and C K Shih, and K Eckner, and S Hattox, and J Adams
August 2019, Antimicrobial agents and chemotherapy,
V J Merluzzi, and K D Hargrave, and M Labadia, and K Grozinger, and M Skoog, and J C Wu, and C K Shih, and K Eckner, and S Hattox, and J Adams
October 2000, AIDS research and human retroviruses,
V J Merluzzi, and K D Hargrave, and M Labadia, and K Grozinger, and M Skoog, and J C Wu, and C K Shih, and K Eckner, and S Hattox, and J Adams
June 1997, Nature medicine,
V J Merluzzi, and K D Hargrave, and M Labadia, and K Grozinger, and M Skoog, and J C Wu, and C K Shih, and K Eckner, and S Hattox, and J Adams
May 1996, Biochemical Society transactions,
V J Merluzzi, and K D Hargrave, and M Labadia, and K Grozinger, and M Skoog, and J C Wu, and C K Shih, and K Eckner, and S Hattox, and J Adams
January 1996, Biochemistry,
V J Merluzzi, and K D Hargrave, and M Labadia, and K Grozinger, and M Skoog, and J C Wu, and C K Shih, and K Eckner, and S Hattox, and J Adams
December 2004, Antimicrobial agents and chemotherapy,
V J Merluzzi, and K D Hargrave, and M Labadia, and K Grozinger, and M Skoog, and J C Wu, and C K Shih, and K Eckner, and S Hattox, and J Adams
June 1997, Biochemistry,
V J Merluzzi, and K D Hargrave, and M Labadia, and K Grozinger, and M Skoog, and J C Wu, and C K Shih, and K Eckner, and S Hattox, and J Adams
January 2014, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!